DICA insights improve results for a great variety of clinical conditions
About the client
The Dutch Institute for Clinical Auditing (DICA) has developed a blueprint and methodology for clinical registries and benchmarking between healthcare providers. DICA facilitates national clinical registries on >20 medical conditions, in a wide range of diseases. DICA collaborates with doctors, patients, and insurers, to continuously improve healthcare by fostering learning cycles and increasing the transparency of care delivered.
DICA’s first registry started in 2009, and was initiated by a group of GE surgeons, part of the Dutch Association of Surgeons (Nederlandse Vereniging voor Heelkunde, NVvH). They embarked on a quest to learn about best practices in colorectal cancer surgery, in order to raise the overall quality of care. They wanted to identify clear-cut areas for improvement in individual hospitals and reduce variation among them. Clinical results would be compiled and published, making a lasting contribution to scientific learning in the field of colorectal cancer surgery.
We wanted to get clarity on the performance for individual hospitals while advancing the quality of care in the Netherlands as a whole.Eric Hans Eddes, Director DICA (Dutch Institute for Clinical Auditing)
To build a robust benchmarking platform that would meet DICA’s needs, a partnership with MRDM (part of LOGEX) was established. MRDM specializes in capturing, processing, and distributing data and information on clinical outcomes, where DICA covers the methodology.
In the last 10 years, with the colorectal cancer surgery registry as a tipping point, DICA and MRDM gradually developed a robust benchmark platform, that today, shows the performance of healthcare institutes relative to their peers, based on standard KPIs developed by medical associations that are methodologically supported by DICA.
The platform currently contains
Hospitals that participate, with >8000 users
Quality & outcome indicators
Bringing clarity to clinical performance, with measurable results
MRDM’s IT platform is designed to support short improvement cycles, empowering providers, and clinical audit boards, with up-to-date information and access to best practices. Advanced filtering options enable the hospitals to benchmark indicators per specific patient profile, thus realizing maximum improvement potential. Data can be updated on a daily basis. When requested by participants, their results can be safely shared with other stakeholders (patient organizations, research, payers, etc.)
As the number one clinical registry technology provider in Europe, LOGEX brings clarity and insight into the clinical performance of medical professionals.
Through our partnership with ICHOM and DICA, we provide disease-specific standard registry sets for our customers. We also support the development of new registries and offer all our customers a registry-specific service desk.
Our Clinical Outcomes solutions enable hospitals and clinics to:
Collect and analyze disease-specific data
Evaluate outcomes for 40 disease groups, zeroing in on areas for improvement.
Benchmark against peers locally and abroad
Benchmark against internationally validated clinical and administrative indicators.
Spot trends and patterns
Filter insights at specialty, diagnosis, and patient levels.
Make informed decisions to improve outcomes
Continuous data updates show areas where you can take decisive action
In addition to weekly updates on clinical performance, DICA publishes the creation of an annual report and annual cycles on governed external transparency. With the benchmarking platform in place, the providers can now zero in on distinct opportunities for improvement and take action to address them. Conditions for which the platform is currently used include oncology, anesthesiology, diabetes, and other internal medicine, surgery (treatment of obesity, breast implants, pediatric surgery), stroke, cataract, and others.
Since the rollout, DICA registries have measured and recorded:
52% lower mortality and 29% fewer severe complications after colorectal cancer surgery
32-minute reduction in time between diagnosis and treatment (door-to-groin-time reduced from 87 to 55 minutes)
The median survival of melanoma patients that have received systemic therapy increased from 12 to 22 months within six years
Increase from 63% to 74,5% in breast-contour-preserving treatments in breast cancer
Radiotherapy before gastrointestinal cancer surgery appeared unnecessary for 800 patients. Protocols have changed accordingly
9% reduction of costs of colorectal cancer surgeries